JPRN-UMIN000001688
Completed
Phase 4
Combination of Antihypertensive therapy in the elderly, Multicenter Investigation <CAMUI> Multi-center randomized controlled study on efficacy of ARB/Diuretic mixture versus ARB/Ca channel blocker combination therapy to blood pressure or cognitive function in the elderly patients who have insufficient controlled hypertension in ARB monotherapy - Combination of Antihypertensive therapy in the elderly, Multicenter Investigation <CAMUI>
Elderly Hypertension Conference0 sites200 target enrollmentFebruary 5, 2009
ConditionsHypertension
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- Elderly Hypertension Conference
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with the secondary hypertension 2\) Patients with heart failure: \>\= NYHA grade III 3\) Patient with a history of severe renal disease: serum creatinine\>\= 2\.0 mg/dl 4\) Patients with critical liver damage: ALT or ASTis 3 times of normal upper level or more 5\) Patients with a history of hypersensitivity to PREMINENT 6\) Patients with a history of hypersensitivity to components of thiazide or similar compounds 7\) Patients who are considered to be not eligible to the study by the investigator due to medical reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The effects of combined therapy for hypertension on arterial functiohypertension, type 2 diabetes mellitusJPRN-jRCT1091220034Masumi Ai, MD, PhDBioethics Research Center, Tokyo Medical and Dental University60
Completed
Not Applicable
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemiaHypertension and dyslipidemiaJPRN-UMIN000008539Saitama Medical Center, Saitama Medical University30
Completed
Phase 4
Comparing anti-hypertensive combination therapy of fixed dose losartan and hydrochlorothiazide(HCTZ) versus angiotensin receptor blocker(ARB) and calcium channel blocker(CCB) on hypertensive patients whose blood pressures don't lower enough,effect and influence of metabolic system trial.HypertensionJPRN-UMIN000001692Hypertension and Metabolism Study group in East Saitama300
Completed
Phase 4
Antihypertensive effect of combination therapy of telmisartan and low dose hydrochrolthiazide in hypertemnsive patientsJPRN-UMIN000000798on profit Organization LINE60
Not yet recruiting
Phase 4
Effect Of Sarpagandha Vati and Haritaki churna in hypertensioCTRI/2024/05/067985Ch Brahm Prakash Ayurved Charak Sansthan